Hangzhou Biotest Biotech Co Ltd (688767) - Total Liabilities

Latest as of September 2025: CN¥134.75 Million CNY ≈ $19.72 Million USD

Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has total liabilities worth CN¥134.75 Million CNY (≈ $19.72 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hangzhou Biotest Biotech Co Ltd (688767) cash conversion ratio to assess how effectively this company generates cash.

Hangzhou Biotest Biotech Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Hangzhou Biotest Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Hangzhou Biotest Biotech Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Hangzhou Biotest Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hangzhou Jizhi Mechatronic Co Ltd SHE:300553	China	CN¥535.15 Million
Zhejiang Xinao Textiles Inc SHG:603889	China	CN¥2.63 Billion
CW Enerji SA IS:CWENE	Turkey	TL14.68 Billion
Canaccord Genuity Group Inc TO:CF	Canada	CA$5.50 Billion
Astra Agro Lestari Tbk JK:AALI	Indonesia	Rp6.96 Trillion
DL Holdings CO. LTD. KO:000210	Korea	₩7.16 Trillion
Shenzhen Fuanna Bedding and Furnishing Co Ltd SHE:002327	China	CN¥1.09 Billion
Shenzhen Sunxing Light Alloys SHG:603978	China	CN¥2.54 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Hangzhou Biotest Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688767 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	13.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Biotest Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Biotest Biotech Co Ltd (2017–2024)

The table below shows the annual total liabilities of Hangzhou Biotest Biotech Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥189.79 Million ≈ $27.77 Million	+19.50%
2023-12-31	CN¥158.82 Million ≈ $23.24 Million	-15.93%
2022-12-31	CN¥188.92 Million ≈ $27.64 Million	-41.58%
2021-12-31	CN¥323.36 Million ≈ $47.32 Million	+69.39%
2020-12-31	CN¥190.89 Million ≈ $27.93 Million	+125.92%
2019-12-31	CN¥84.50 Million ≈ $12.36 Million	+49.60%
2018-12-31	CN¥56.48 Million ≈ $8.27 Million	+17.96%
2017-12-31	CN¥47.88 Million ≈ $7.01 Million	--

About Hangzhou Biotest Biotech Co Ltd

SHG:688767 China Biotechnology

Market Cap

$907.96 Million

CN¥6.20 Billion CNY

Market Cap Rank

#9650 Global

#2721 in China

Share Price

CN¥41.55

Change (1 day)

+2.09%

52-Week Range

CN¥30.56 - CN¥48.37

All Time High

CN¥125.45